Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
Robert PrzybylskiLogan M EberlyMark E AlexanderVassilios J BezzeridesElizabeth S DeWittAudrey DionneDouglas Y MahJohn K TriedmanEdward P WalshEdward T O'LearyPublished in: Journal of cardiovascular electrophysiology (2023)
Flecainide was more effective than propafenone. We did not detect a difference in rate of conversion to sinus rhythm between patients with and without CHD and were likely underpowered to do so, however, there was a trend toward decreased likelihood of success in patients with CHD. That said, medical therapy was effective in >50% of patients with CHD with AF.
Keyphrases
- atrial fibrillation
- congenital heart disease
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- healthcare
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- coronary artery disease
- middle aged
- blood pressure
- mesenchymal stem cells
- heart rate
- drug induced
- cell therapy
- mitral valve
- replacement therapy